News & Events

Winners Announced for the 2025 Vivli AMR Surveillance Data Challenge, funded by Johnson & Johnson, Paratek, Pfizer, and NIH

Vivli is pleased to announce the awardees of the 2025 Vivli AMR (Antimicrobial Resistance) Surveillance Data Challenge, funded by Johnson & Johnson, Paratek, Pfizer, and a U.S. National Institutes of Health award.* The data challenge aims to stimulate and support the re-use of surveillance data available in the Vivli AMR Register with the goal of developing innovative tools to address AMR, a leading threat to global public health.

A total of 58 teams with members from 22 different countries participated in the third annual challenge. The event offered the opportunity for these multidisciplinary teams to leverage high-quality industry AMR surveillance data and address important questions related to AMR. The Challenge culminated in the recognition of six outstanding winners and one honorable mention, selected by a distinguished judging panel.

This year, Vivli offered two Grand Prizes: the AMR Global Leadership Award Grand Prize and the AMR Visionary Award Grand Prize.

The AMR Global Leadership Award Grand Prize was awarded to a team led by George Priya Doss Chandrakumar (Vellore Institute of Technology) with team members Vasundhara Karthikeyan (Georg August Universität Göttingen), Shraddha Karve (Ashoka University), and Sree Haryini Sivasubramanian (Vellore Institute of Technology). The team used Pfizer’s SENTRY dataset (ATLAS_Antifungals) from the United States and Europe, along with the KEYSTONE, ATLAS_Antibiotics, GEARS, PLEA (Study I), GASAR (Study III), and PLEA (Study II) datasets. They examined the impact of air pollution on resistance to fluconazole in C. glabrata. Notably, their timeseries analysis reveals that time-lag effects play a significant role in predicting trends in resistance.

“Through temporal analysis, we identified a delayed correlation between exposure to airborne contaminants and the emergence of drug-resistant phenotypes, implying that environmental stressors may exert a cumulative influence on microbial resistance trajectories,” said Chandrakumar. “Engagement in the Vivli AMR Surveillance Data Challenge enabled us to harness globally sourced datasets in a novel analytical framework. We are honored that our findings have garnered recognition.”

The AMR Visionary Award Grand Prize was awarded to Claire Vania (St. Jude Children’s Research Hospital) and Anushruti Gupta (Johns Hopkins University). Using datasets contributed by Merck, Pfizer, Shionogi, and Venus Remedies, as well as additional public datasets, they built a model to help predict how different policies and antibiotic use practices might affect the rise of antimicrobial resistance.

“We applied machine learning to global AMR data to predict antimicrobial resistance patterns under different policy scenarios, providing insights that can support policymakers in shaping strategies to combat AMR,” said Vania. “Participating in this challenge was exciting because it allowed us to contribute innovative methods that have a real potential for global health impact.”

The Student Innovation Award winner was a team from the University of Oxford. Team members included Jake Hitch (Team lead), Nicolas Armijo Escalona, Augustine Luk, Ashley Murray, and Natasha Salant. The team used advanced modeling techniques to provide more insight into when to escalate antibiotic treatment compared to conventional techniques. Their approach allows for partial pooling of information across countries, enabling the model to “borrow strength” from datarich regions and improve predictions in countries with sparse surveillance information. This makes it a valuable tool for improving antibiotic decisions, especially in low-resource settings, and helps reduce the use of overly broad antibiotics.

Reflecting on this year’s challenge, Data Challenge Judge Marc Mendelson, MBBS, PhD, Chair of the Vivli AMR Scientific Advisory Board, Professor of Infectious Diseases, and Head of the Division of Infectious Diseases and HIV Medicine at the Groote Schuur Hospital at the University of Cape Town, said, “This year’s Vivli AMR Data Challenge saw another step up in quality of the submitted data solutions and breadth of applications for which the data was used. I would like to congratulate all applicants, our finalists, and especially this year’s winners.”

“Particularly pleasing was the increased number of submissions and high standard of solutions in the student category. Such was the quality of applications that the judges decided to award two prizes in this category. Many congratulations to both winners. It is clear that the use of data science to find novel ways of interpreting and using the data to mitigate AMR is in good hands.”

Data Challenge Judge Ana Cristina Gales, MD, PhD, Professor in the Division of Infectious Diseases at Escola Paulista de Medicina, Universidade Federal de São Paulo, agrees, “I was impressed by the significant increase in the number of proposals submitted this year, particularly from students. Even more remarkable was the clear improvement in the quality of submissions.”

Dr. Gales also encourages teams to begin preparing early for next year’s competition, “I warmly congratulate the winners and encourage those who were not selected to challenge themselves further and submit even stronger proposals in 2026, taking into consideration a One Health approach to tackle AMR. Our future depends on our commitment to addressing AMR. Antimicrobials are precious and must be safeguarded for future generations.”

The full roster of awards is listed below. Explore the teams’ solutions.

Grand Prizes

  • AMR Global Leadership Award Grand Prize: George Priya Doss Chandrakumar (Team lead, Vellore Institute of Technology), Vasundhara Karthikeyan (Georg August Universität Göttingen), Shraddha Karve (Ashoka University), and Sree Haryini Sivasubramanian (Vellore Institute of Technology), “Causal inference of antimicrobial resistance trends: Evaluating the impact of climate and pollution using global AMR data.”
  • AMR Visionary Award Grand Prize: Claire Vania (St. Jude Children’s Research Hospital) and Anushruti Gupta (Johns Hopkins University), “A counterfactual machine learning approach to evaluating AMR policy impact.”

AMR Student Innovation award

  • Team from University of Oxford, Jake Hitch (Team lead), Nicolas Armijo Escalona, Augustine Luk, Ashley Murray, and Natasha Salant, “Improving evidence-based antibiotic escalation in bloodstream infections in low-resource settings using Bayesian statistical and machine learning approaches.”

AMR Student Impact award

  • Team from University of Ibadan, Marvellous Adeoye (Team lead), Joseph Adegoke, Elizabeth Akande, Josephine Mayokun Binuyo, and Bridget Osuji, “Genomic–phenotypic association for AMR drug-target discovery.”

AMR Impact award

  • Righteous Kwaku Agoha (Team lead, University of Ghana), Wendy Akushika Dogbegah (University of Ghana), Albert Yao Kudakpo (University of Ghana), Dorvi Ignatus Nunana (University of Ghana), and Stephen Obol Opiyo (The Ohio State University), “Multidimensional surveillance of AMR in North and Central America using species, age, geographic, and genomic insights.”

AMR Innovation award

  • Team from Conservatoire National des Arts et Métiers, Quentin Leclerc (Team lead), Chloé Aupépin, Eve Rahbé, and Laura Temime,“Missing the (break)point? Comparing the use of ECOFFs and clinical breakpoints to study global AMR trends.”

AMR Honorable Mention for Impact

  • Team from Institut Pasteur/INSERM/Université de Versailles – Saint-Quentin-en-Yvelines, Maria Alexa (Team lead), Sophie Chervet, Maylis Layan, Lulla Opatowski, and Camille Schneider, “Tracking the dissemination of emerging Resistant Genes (TrackR-G).”

 

Contact: Amanda Skarlupka, Rebecca Li

*Funded in part by NIH Award, “Generalist Repository Ecosystem Initiative (GREI),” Other Transaction Agreement No.: 1OT2DB000003-01.


About Vivli

Vivli is a non-profit organization working to advance human health through the insights and discoveries gained by sharing and analyzing data. Data sharing initiatives include the AMR Register for AMR surveillance data and the Vivli Platform for clinical trial data. Vivli acts as a neutral broker between data contributor and data user and the wider data sharing community. For more information, visit www.vivli.org and follow us on LinkedIn and Bluesky.

Breaking News – Vivli announces the 2025 AMR Surveillance Data Challenge to Initiate April 15th

Vivli is excited to announce the launch of the 2025 Vivli AMR Surveillance Data Challenge, opening on April 15, 2025. Now in its third year, this global competition is funded by Johnson & Johnson, Paratek, Pfizer, and an NIH award* and is designed to stimulate innovative reuse of antimicrobial resistance (AMR) surveillance data housed in the AMR Register.

This Challenge invites multidisciplinary research teams to harness high-quality industry AMR surveillance data to tackle critical questions in AMR. Participants will compete for prestigious awards by generating new insights that contribute to the global fight against antimicrobial resistance.

Participants will use high-quality industry data from the AMR Register, which has been significantly expanded this year with new datasets and refreshed with new datasets. This is a unique opportunity for researchers across disciplines to generate fresh insights and contribute meaningfully to the global effort to combat AMR.

What prizes can be won?

A total of 5 awards will be provided that are associated with monetary awards and/or travel

  • 2 Grand Prize Awards –
    • AMR Global Leadership Award Grand Prize
    • AMR Visionary Award Grand Prize
      • Each for $10,000 and a travel grant of $5,000 to travel to an infectious disease conference 2026 if an abstract is accepted
  • 1 AMR Student Innovation Award –receiving a travel grant of $5,000 to travel to an infectious disease conference in 2026, if their abstract is accepted
  • 2 Awards – 1 Award in AMR Impact, 1 Award in AMR Innovation; Each receiving $5,000 and a travel grant of $2,000 to travel to an infectious disease conference in 2026, if their abstract is accepted

Sign up to the data challenge Slack Channel to be notified when the challenge is open and to keep updated about the latest information and details about this data challenge.

* Funded in part by NIH Award
Generalist Repository Ecosystem Initiative (GREI)
Other Transaction Agreement No.: 1OT2DB000003-

AMR Webinar: NIH’s Data Sharing and Reuse Seminar Series: The Vivli AMR Data Challenge as a Use Case

This webinar, hosted by the NIH, explores the critical role of data sharing and re-use and demonstrates how data sharing can be effective using a case study in the area of anti-microbial resistance (AMR) using the real-world AMR data challenge as a use case. Experts and Global Grand prize data challenge awardees from 2023 and 2024 discuss best practices for overcoming barriers to data accessibility, ensuring responsible re-use, and fostering international collaboration through the mechanism of a data challenge. A key focus is the AMR Register run by Vivli, a global data-sharing platform designed to facilitate access to antimicrobial resistance data, enhance transparency, and drive innovative solutions in AMR research.

Watch Recording

Speakers:

  • Kasim Allel, Ph.D., Researcher, University of Oxford, UK and AMR Global Grand Prize data challenge awardee 2024
  • Fred Mutisya, M.D., Field Epidemiology Resident, Kenya and AMR Global Grand Prize data challenge awardee 2023, AMR Global Impact data challenge awardee 2024
  • Patricia Bradford, Ph.D., Microbiology Consultant, Antimicrobial Development Specialists, LLC
  • Rebecca Li, Ph.D., Vivli CEO and Board Member

Watch Recording

Winners Announced for the 2024 AMR Surveillance Data Challenge, funded by GARDP, Paratek, Pfizer and Vivli

Vivli is pleased to announce the awardees of the 2024 AMR (Antimicrobial Resistance) Surveillance Data Challenge. The Data Challenge aims to stimulate and support the innovative re-use of surveillance data available in the AMR Register.

The AMR Data Challenge, funded by GARDP, Paratek, Pfizer and Vivli, was launched in June 2024, as a catalyst for innovation and support for the inventive reutilization of the wealth of surveillance data available within the AMR Register.

Data challenge judge Seamus O’Brien, Director of Research & Development at Global Antibiotic Research & Development Partnership (GARDP) which helped to fund the challenge, said, “The Data Challenge demonstrates the value of open access to AMR surveillance data through the creativity of the applicants in applying this data to innovative AMR solutions.”

A total of 55 teams with members from 27 different countries participated in the AMR Data Challenge. This event served as a unique platform for multidisciplinary teams to leverage high-quality industry AMR surveillance data, proposing groundbreaking advancements and tools for use in AMR surveillance. The Challenge culminated in the recognition of six outstanding winners, selected by a distinguished judging panel.

The Grand Prize was awarded to a team from University of Oxford, UK, – Kasim Allel, David Smith, Koen Pouwels, Nam Nguyen, and Sam Lipworth. The team used the Pfizer ATLAS dataset to develop a flexible spatiotemporal modelling framework to predict AMR dynamics from routine surveillance data, and to identify key change points in epidemiological trends.

Dr Kasim Allel, researcher at the University of Oxford’s Health Economics Research Centre, said, “Participating in this prestigious data challenge has been a profoundly rewarding experience for our team, and winning it has further strengthened our commitment to using data to drive impactful health solutions. We are particularly grateful to Vivli for creating such an accessible and supportive platform. This experience underscores the critical importance of early detection of changes in antimicrobial resistance (AMR) trends and the development of early warning systems that empower communities, including those with limited resources, to address AMR challenges more proactively.”

The Student Innovation award winners were a team from Northeastern University, USA – Harry Akligoh, Charlie Huh and Thomas Lim with Alexander Kwakye from Stony Brook University, USA. The team used the Pfizer ATLAS dataset to develop microBIS, a laboratory assistant in the form of an interactive web app for bacterial identification, AMR prediction and data management. Without the need for expensive equipment, the platform empowers healthcare providers to deliver high-quality care regardless of their resource constraints.

“The Vivli AMR Surveillance Data Challenge has been an exciting opportunity and a crucial milestone in our innovation journey,” said Akligoh. “With our diverse backgrounds in medical laboratory science, bioengineering, population genetics, and data science, through hard work and perseverance, we managed to create a novel web-based laboratory assistant with immense potential to drive meaningful progress in AMR diagnosis, research and development, of which we are immensely proud!”

Other notable awardees and their project titles include:

  • Impact Award Winner: team from Chuka County Referral Hospital and Narok County Government, Kenya, led by Rachael Kanguha

Project title: “Using AI to Incorporate Dynamic Antibiograms and Research into Electronic Medical Records for antibiotic decision support”

  • Impact Award Winner: team from Institut Pasteur, France, London School of Hygiene & Tropical Medicine, and City St. George’s University of London, UK, led by Quentin Leclerc 

Project title: “Rethinking AMR sampling: can non-sterile samples predict resistance in blood/sterile samples at a country level?”

  • Innovation Award: team from Indraprastha Institute of Information Technology Delhi (IIIT-Delhi), India, led by Tavpritesh Sethi

Project title: “AMROrbit Scorecard: A Dynamic Phase Space Model for Strategic Monitoring and Actionable Insights on Global AMR Trajectories”

  • Innovation Award Winner: team from London School of Hygiene & Tropical Medicine, UK, led by Naomi Waterlow

Project title: “Unveiling the Sex-Specific Impact on Antimicrobial Resistance (AMR): A Bayesian Hierarchical Model Approach Using Vivli Data”

  • An Honorable Mention for Impact goes to the team from University of Ibadan, Nigeria, led by Christian Tochukwu Agboeze

Project title: “Predictive Analytics and Genotypic Evaluation for AMR in Africa (PANGEA)”

Data contributed by GSK, Johnson & Johnson, Paratek, Pfizer, Shionogi, and Venatorx was made accessible through the AMR Register, significantly enhancing the impact of the Challenge.

“The Vivli AMR surveillance Open Re-use Challenge has gone from strength to strength in its second iteration,” said Prof. Marc Mendelson, Chair of the Vivli AMR Scientific Advisory Board, Professor of Infectious Diseases and Head of the Division of Infectious Diseases & HIV Medicine, Groote Schuur Hospital, University of Cape Town. “Solutions were largely driven by innovation in the use of AI, machine learning, prediction models and innovative modelling methodology to bring impactful change to the way we use surveillance data. Congratulations to all the teams who entered. The standard was extremely high across the board and we all look forward to following the winners’ progress.”

For more details and to view the winning teams’ solutions, please visit https://amr.vivli.org/data-challenge/finalist-and-award-winning-solutions.

Contact: Catherine D’Arcy, Rebecca Li

_______________________________________________________________________________

About Vivli

Vivli is a non-profit organization working to advance human health through the insights and discoveries gained by sharing and analyzing data. Data sharing initiatives include the AMR Register for AMR surveillance data and the Vivli Platform for clinical trial data. Vivli acts as a neutral broker between data contributor and data user and the wider data sharing community. For more information, visit www.vivli.org and follow us on LinkedIn and Twitter @VivliCenter.



Venus Remedies joins Vivli’s AMR Register as a Member to Share its Data

“We are delighted to have Venus Remedies join as a member of the AMR register,” said Rebecca Li, Vivli CEO. “We look forward to working with the team at Venus Remedies to share their AMR surveillance data to further help in the fight against AMR.”

“At Venus Remedies, we are firm believers in the power of open data and collaboration to tackle global challenges like antimicrobial resistance. By joining Vivli’s AMR Register, we are committed to sharing our surveillance data openly with the global research community, helping to drive collective action and accelerate solutions to this pressing health threat,” said Saransh Chaudhary, CEO – Venus Medicine Research Centre.

For more information about the studies Venus Remedies are sharing on the AMR Register, please visit the surveillance programs pages and their member page. For additional information about Membership in Vivli’s AMR Register, learn more here.

2023 Data Challenge winning solutions published in Wellcome Open Research collection

Vivli is delighted to announce the publication of a new collection in Wellcome Open Research showcasing the finalists and winners of the 2023 Vivli AMR Surveillance Open Data Re-Use Data Challenge, funded by Wellcome. This growing collection includes nine articles from participating research teams, as well as an editorial co-authored by members of the judges’ panel and Vivli team. 

This collection is envisioned as a living resource, and finalists and winners from the 2024 Vivli AMR Surveillance Data Challenge, funded by GARDP, Paratek, Pfizer, and Vivli, that is currently underway, will also be invited to submit an article. The included articles highlight the range of diverse, impactful, and innovative solutions developed by the teams participating in the Data Challenge, leveraging data from the Vivli Antimicrobial Resistance (AMR) Register to contribute to resolving the AMR crisis. The first two articles to complete peer review approval are now available on the Wellcome Open Research website: 

From our Grand Prize winning team –

Investigating the feasibility and potential of combining industry AMR monitoring systems: a comparison with WHO GLASS” by Fredrick Mutisya and Rachael Kanguha

From an Impact Award winning team –

MIC distribution analysis identifies differences in AMR between population sub-groups” by Eve Rahbé, Aleksandra Kovacevic, Lulla Opatowski, and Quentin J. Leclerc

The escalation of infections caused by drug-resistant bacteria worldwide poses a formidable challenge to global health, necessitating innovative approaches to combat this issue. The Vivli AMR Register consolidates antimicrobial susceptibility data from pharmaceutical industry surveillance programs, advancing the fight against antimicrobial resistance through the power of open data and collaboration.

Learn more about the Vivli AMR Register and how you can get involved in the 2024 Data Challenge

Vivli team to speak at GARDP REVIVE webinar on July 23rd

Vivli CEO, Rebecca Li and Antimicrobial Development Consultant Patricia Bradford, will speak at the GARDP REVIVE webinar entitled “The value of surveillance data in defining the medical need for new antimicrobials” on July 23rd. Rebecca will speak on the Vivli AMR Register as a mechanism for sharing and re-use for industry surveillance data, and Patricia will describe the latest 2024 Vivli AMR Surveillance Data Challenge and review the 2023 Data Challenge. Sign up now!

Interactive Q & A will be available to enable audience participation.

Breaking News – Vivli announces the 2024 AMR Surveillance Data Challenge, funded by GARDP, Paratek, Pfizer and Vivli, to Initiate June 17th

Vivli is launching the 2024 Vivli AMR Surveillance Data Challenge, funded by GARDP, Paratek, Pfizer and Vivli, on 17th June. The data challenge aims to stimulate and support the innovative re-use of surveillance data available in the AMR Register.

This Challenge provides an opportunity for multidisciplinary teams to win prizes by using high-quality industry AMR surveillance data to answer pressing research questions.  The data will be shared through the AMR Register.

A series of prizes can be won by research teams from any discipline who find new insights in the data and contribute to the fight against antimicrobial resistance.

What prizes can be won?

A total of 6 awards will be provided that are associated with monetary awards and/or travel

  • Grand Prize Award – $10,000 and a travel grant of $5,000 to travel to ESCMID Global or ASM Microbe in 2025, if their abstract is accepted
  • 4 awards – Each receiving $5,000 and a travel grant of $2,500 to travel to ESCMID Global or ASM Microbe in 2025, if their abstract is accepted – 2 in Innovation and 2 in Impact
  • 1 AMR Student Innovation Award – a travel grant of $5,000 to travel to ESCMID Global or ASM Microbe in 2025, if their abstract is accepted

Sign up to the data challenge Slack Channel to be notified when the challenge is open and to keep updated about the latest information and details about this data challenge.

What’s involved?

On June 17, 2024, teams will be invited to register and submit a short summary of the research they intend to undertake with the data (an Expression of Interest or EOI). The EOIs will be reviewed, and teams will be given access to the data for a 30-day window, during which solutions must be submitted.

These submissions will be reviewed by a panel of judges and finalists selected. Finalists will have the opportunity to pitch their idea to a panel of judges via Zoom and the prize winners will be chosen.

Announcement: New Wellcome Open Research Article on the Vivli AMR Register

We are pleased to announce the publication of a new article in Wellcome Open Research detailing the impactful use of data from the Vivli AMR Register. This article highlights how the register has served as a unique platform for 56 teams to leverage high-quality industry surveillance data.

The escalation of infections caused by drug-resistant bacteria worldwide poses a formidable challenge to global health, necessitating innovative approaches to combat this issue. In 2022, Vivli launched the Antimicrobial Resistance (AMR) Register, a platform that consolidates antimicrobial susceptibility data from pharmaceutical industry surveillance programs. This register provides a freely available and fully searchable user-friendly repository to facilitate scientific understanding of resistance patterns and support the development of innovative strategies to address AMR globally.

To promote the register’s utility, raise AMR awareness, and encourage further re-use of the available data, Wellcome funded the Vivli AMR Surveillance Open Data Re-Use Data Challenge in 2023. This 2023 data challenge successfully fostered diverse, impactful, and innovative solutions that leveraged the AMR Register data to contribute to resolving the AMR crisis. The outcomes of the initiative underscored the importance of access to open data in stimulating collaboration and innovation in the public health domain, particularly in combating the growing threat of drug-resistant infections.

We invite you to read the full editorial to learn more about how the Vivli AMR Register is advancing the fight against antimicrobial resistance through the power of open data and collaboration.